- Home
- ADUR vs AVR Comparison
ADUR vs AVR Comparison
Compare ADUR & AVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADUR
- AVR
- Stock Information
- Founded
- ADUR 2011
- AVR 1999
- Country
- ADUR Canada
- AVR Australia
- Employees
- ADUR N/A
- AVR N/A
- Industry
- ADUR
- AVR
- Sector
- ADUR
- AVR
- Exchange
- ADUR NYSE
- AVR NYSE
- Market Cap
- ADUR 162.6M
- AVR 162.1M
- IPO Year
- ADUR N/A
- AVR 2024
- Fundamental
- Price
- ADUR $9.00
- AVR $3.73
- Analyst Decision
- ADUR Strong Buy
- AVR Strong Buy
- Analyst Count
- ADUR 1
- AVR 4
- Target Price
- ADUR $48.00
- AVR $16.50
- AVG Volume (30 Days)
- ADUR 403.4K
- AVR 294.3K
- Earning Date
- ADUR 01-01-0001
- AVR 08-16-2025
- Dividend Yield
- ADUR N/A
- AVR N/A
- EPS Growth
- ADUR N/A
- AVR N/A
- EPS
- ADUR N/A
- AVR N/A
- Revenue
- ADUR $179,327.00
- AVR $2,493,000.00
- Revenue This Year
- ADUR N/A
- AVR $25.79
- Revenue Next Year
- ADUR N/A
- AVR $211.91
- P/E Ratio
- ADUR N/A
- AVR N/A
- Revenue Growth
- ADUR N/A
- AVR N/A
- 52 Week Low
- ADUR $2.86
- AVR $2.34
- 52 Week High
- ADUR $11.97
- AVR $8.79
- Technical
- Relative Strength Index (RSI)
- ADUR N/A
- AVR N/A
- Support Level
- ADUR N/A
- AVR N/A
- Resistance Level
- ADUR N/A
- AVR N/A
- Average True Range (ATR)
- ADUR 0.00
- AVR 0.00
- MACD
- ADUR 0.00
- AVR 0.00
- Stochastic Oscillator
- ADUR 0.00
- AVR 0.00
About ADUR ADURO CLEAN TECHNOLOGIES INC
Aduro Clean Technologies Inc is a developer of patented water-based technologies to chemically recycle plastics and transform heavy crude and renewable oils into feedstocks and higher-value fuels. The company's technology activates unique properties of water in a chemistry platform that operates at relatively low temperatures and costs.
About AVR ANTERIS TECHNOLOGIES GLOBAL CORP
Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.